Another week, another set of clinically relevant research findings that incrementally advance our efforts to better prevent HIV and provide care to people living with the virus. On tap this week, we take a brief look at the following study results:
- Following incarceration, HIV outcomes appear to be poorer among women than men.
- Even in rare cases where people prescribed pre-exposure prophylaxis (PrEP) become HIV positive, drug resistance doesn't occur.
- In the long run, a nurse-led HIV treatment adherence self-management program appears to be worth its slightly higher cost.
- Much like the general population, HIV-positive cancer survivors are at risk for developing additional cancers.
Let's examine each of these findings in a little more detail. To beat HIV, you have to follow the science!